[1]
2021. Comparative study on efficacy and safety of Rosuvastatin v/s Atorvastatin in patients with metabolic syndrome- a prospective observational study. International Journal of Research in Pharmacology & Pharmacotherapeutics. 8, 3 (Apr. 2021), 326–334. DOI:https://doi.org/10.61096/ijrpp.v8.iss3.2019.326-334.